BLAC (Bellevue Life Sciences Acquisition) Effective Interest Rate on Debt % : 0.00% (As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Bellevue Life Sciences Acquisition Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Bellevue Life Sciences Acquisition's annualized positive value of Interest Expense for the quarter that ended in Sep. 2024 was $0.00 Mil. Bellevue Life Sciences Acquisition's average total debt for the quarter that ended in Sep. 2024 was $1.64 Mil. Therefore, Bellevue Life Sciences Acquisition's annualized Effective Interest Rate on Debt % for the quarter that ended in Sep. 2024 was 0.00%.

Bellevue Life Sciences Acquisition Effective Interest Rate on Debt % Historical Data

The historical data trend for Bellevue Life Sciences Acquisition's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bellevue Life Sciences Acquisition Effective Interest Rate on Debt % Chart

Bellevue Life Sciences Acquisition Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Effective Interest Rate on Debt %

Bellevue Life Sciences Acquisition Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Effective Interest Rate on Debt %	Get a 7-Day Free Trial									-	-	-	-	-

Competitive Comparison of Bellevue Life Sciences Acquisition's Effective Interest Rate on Debt %

For the Shell Companies subindustry, Bellevue Life Sciences Acquisition's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bellevue Life Sciences Acquisition's Effective Interest Rate on Debt % Distribution in the Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Bellevue Life Sciences Acquisition's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Bellevue Life Sciences Acquisition's Effective Interest Rate on Debt % falls into.

Save Embed

;

Save Embed

;

Bellevue Life Sciences Acquisition Effective Interest Rate on Debt % Calculation

Bellevue Life Sciences Acquisition's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2023 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (A: Dec. 2022 )	+	Total Debt (A: Dec. 2023 ))	/ count )
=	-1 * 0	/	( (1.2	+	0)	/ 1 )
=	-1 * 0	/	1.2
=	0.00 %

where

	Total Debt (A: Dec. 2022 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0	+	1.2
=	1.2

	Total Debt (A: Dec. 2023 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0	+	0
=	0

Bellevue Life Sciences Acquisition's annualized Effective Interest Rate on Debt % for the quarter that ended in Sep. 2024 is calculated as

	Effective Interest Rate on Debt %
=	-1 * Interest Expense	/	( (Total Debt (Q: Jun. 2024 )	+	Total Debt (Q: Sep. 2024 ))	/ count )
=	-1 * 0	/	( (1.498	+	1.778)	/ 2 )
=	-1 * 0	/	1.638
=	0.00 %

where

	Total Debt (Q: Jun. 2024 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0	+	1.498
=	1.498

	Total Debt (Q: Sep. 2024 )
=	Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation
=	0	+	1.778
=	1.778

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Sep. 2024) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

Bellevue Life Sciences Acquisition (NAS:BLAC) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.

Bellevue Life Sciences Acquisition Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Bellevue Life Sciences Acquisition's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.

Bellevue Life Sciences Acquisition Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Bellevue Life Sciences Acquisition Corp (NAS:BLAC) » Definitions » Effective Interest Rate on Debt %

Comparable Companies

Traded in Other Exchanges

N/A

Address

10900 NE 4th Street, Suite 2300, Bellevue, WA, USA, 98004

Website

https://www.bellevuespac.com

Bellevue Life Sciences Acquisition Corp is a blank check company.

Executives

David Jin Yoo	officer: Chief Financial Officer	(135-270) 7TH FLOOR, SOFTFORUM B/D., 545-7 DOGOKDONG, GANGNAM, SEOUL M5 135-170
Kuk Hyoun Hwang	director, 10 percent owner, officer: Chief Executive Officer	10900 NE 4TH STREET, SUITE 2300, BELLEVUE WA 98004
Bellevue Global Life Science Investors Llc	10 percent owner	10900 NE 4TH STREET, SUITE 2300, BELLEVUE WA 98004
Steven Reed	other: Director Nominee	2843-122 PL. N.E., BELLEVUE WA 98005
In Chul Chung	other: Director Nominee	10900 NE 4TH STREET, SUITE 2300, BELLEVUE WA 98004
Hosun Euh	other: Director Nominee	10900 NE 4TH STREET, SUITE 2300, BELLEVUE WA 98004
Jin Whan Park	other: Director Nominee	10900 NE 4TH STREET, SUITE 2300, BELLEVUE WA 98004
Jun Chul Whang	director	10900 NE 4TH STREET, SUITE 2300, BELLEVUE WA 98004
Rad Roberts	other: Director Nominee	10900 NE 4TH STREET, SUITE 2300, BELLEVUE WA 98004